Advanced search
Publication Cover
Modern Rheumatology Volume 23, 2013 - Issue 2
Journal homepage
107
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab

Mie FusamaDivision of Nursing, NTT West Osaka Hospital, Osaka, Japan;Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan
,
Hideko NakaharaDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, JapanCorrespondence[email protected]
,
Yoshimasa HamanoDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
,
Masayuki NishideDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
,
Keisuke KawamotoDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
,
Takashi HosokawaDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
,
Satoko NozatoDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
,
Shinji HigaDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
,
Tsuyoshi IgarashiDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
,
Eiji TakeuchiDepartment of Orthopaedic Surgery, NTT West Osaka Hospital, Osaka, Japan
,
Takanori KuroiwaDepartment of Internal Medicine, Yukioka Hospital, Osaka, Japan
,
Yasunori ShimaokaDepartment of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan
,
Masao YukiokaDepartment of Orthopaedic Surgery, Yukioka Hospital, Osaka, Japan
,
Yasushi MiuraDepartment of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan
,
Kayoko HigashiDivision of Nursing, NTT West Osaka Hospital, Osaka, Japan
,
Taro KuritaniDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
&
Keiji MaedaDivision of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, 2-6-40 Karasugatsuji, Tennoji-ku, Osaka 543-8922, Japan
 show all
Pages 276-283 | Received 10 Jan 2012, Accepted 16 Apr 2012, Published online: 02 Jan 2014

REFERENCES

  • Harris ED Jr. Rheumatoid arthritis. Pathophysiology and impli-cations for therapy. N Engl J Med. 1990;322:1277–89.
  • Meenan RF, Yelin EH, Nevitt M, Epstein WV. The impact of chronic disease: a sociomedical profile of rheumatoid arthritis. Arthritis Rheum. 1981;24:544–9.
  • Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: rec-ommendations of an international task force. Ann Rheum Dis. 2010;69:631–7.
  • Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 2000;59(Suppl
  • Nishimoto N. Interleukin-6 in rheumatoid arthritis. Curr Opin Rheumatol. 2006;18:277–81.
  • Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J, et al. Study of active controlled tocilizumabmonotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy. Mod Rheumatol. 2009;19:12–9.
  • Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an X ray reader-blinded randomized controlled trial of tocilizumab. Ann Rheum Dis. 2007;66:1162–7.
  • Genovese MC, Mckay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, et al. Interleukin-6 receptor inhibition with toc-ilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs. Arthritis Rheum. 2008;38:2968–80.
  • Amett FC, Amett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. The American Theumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
  • Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Com-parison of disease activity score (DAS) 28-erythrocyte sedimen-tation rate and DA528-C-reactive protein threshold values. Ann Rheum Dis. 2007;66: 407–9.
  • Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(Suppl 39):S100–8.
  • Meenan RF, Mason H, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Mesurement Scales Health Status Questionnaire. Arthritis Rheum. 1992;35: 1–10.
  • Ware JE, Sherboume CD. The Medical Outcomes Study (MOS) 36-item short-form health survey (SF-36): I. Conceptual frame-work and item selection. Med Care. 1992;30:473–83.
  • Kosinski M, Kujawski SC, Martin R, Wanke LA, Buatti MC, Ware JE Jr, et al. Health-related quality of life in early rheuma-toid arthritis: impact of disease and treatment response. Am J Manag Care. 2002;8:231–40.
  • Salaffi F, Stancati A, Carotti M. Responsiveness of health status measures and utility-based methods in patients with rheumatoid arthritis. Clin Rheumatol. 2002;21:478–87.
  • Ban A, Inaba M, Furumitsu Y, Okamoto K, Yukioka K, Goto H, et al. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infiiximab. Biomed Pharmacother. 2010;64:107–12.
  • ten Klooster PM, Veehof MM, Taal E, van Riel PL, van de Laar MA. Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Ann Rheum Dis. 2007;65: 1485–90.
  • Veehof MM, ten Klooster PM, Taal E, van Riel PLCM, van de Laar MAF. Comparison of internal and external responsiveness of the generic medical outcome study Short Form-36 (SF-36) with disease-specific measures in rheumatoid arthritis. J Rheu-matol. 2008;35:610–7.
  • Heiberg T, Finset A, Uhlig T, Kvien TK. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis. 2005;64:191–5.
  • Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest pri-ority. Arthritis Rheum. 2002;47:391–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.